| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Obstetrics, Gynecology, and Women’s Health, New Jersey Medical School, Newark, New Jersey 07103; and Isis Pharmaceuticals (B.P.M.), Carlsbad, California 92008
Address all correspondence and requests for reprints to: Dr. Laura T. Goldsmith, Department of Obstetrics, Gynecology, and Women’s Health, New Jersey Medical School, 185 South Orange Avenue, Newark, New Jersey 07103. E-mail: goldsmit{at}umdnj.edu
Despite the importance of relaxin to normal parturition in various species and its potential as an etiological agent in preterm delivery in women, knowledge regarding the mechanisms by which relaxin alters cervical connective tissue is extremely limited. An established in vitro model for human pregnancy cervix, human lower uterine segment fibroblasts, was used to determine the effects of relaxin as well as those of progesterone on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase-1. The results demonstrate that relaxin is a positive regulator of matrix metalloproteinase expression, as it stimulates the expression of procollagenase protein and mRNA levels, stimulates prostromelysin-1 protein and mRNA levels, and inhibits tissue inhibitor of metalloproteinase-1 protein expression. Stimulation of procollagenase and prostromelysin-1 expression by relaxin does not involve phorbol-12-myristate-13-acetate- sensitive PKCs. Relaxin-stimulated tyrosine phosphorylation of the putative receptor and inhibition by a receptor tyrosine kinase inhibitor suggest that the relaxin receptor is probably a tyrosine kinase receptor. Inhibition of c-Raf protein expression using an antisense oligonucleotide inhibits relaxin regulation of matrix metalloproteinase and tissue inhibitor of metalloproteinase-1, suggesting that a signaling pathway involving c-Raf kinase mediates relaxin action.
This article has been cited by other articles:
 |
|
 |
|
  M. Koizumi, M. Momoeda, H. Hiroi, F. Nakazawa, H. Nakae, T. Ohno, T. Yano, and Y. Taketani Inhibition of proteases involved in embryo implantation by cholesterol sulfate Hum. Reprod., November 7, 2009; (2009) dep370v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Simon and A. Einspanier The hormonal induction of cervical remodeling in the common marmoset monkey (Callithrix jacchus) Reproduction, March 1, 2009; 137(3): 517 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Halls, E. T. van der Westhuizen, J. D. Wade, B. A. Evans, R. A. D. Bathgate, and R. J. Summers Relaxin Family Peptide Receptor (RXFP1) Coupling to G{alpha}i3 Involves the C-Terminal Arg752 and Localization within Membrane Raft Microdomains Mol. Pharmacol., February 1, 2009; 75(2): 415 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Samuel, T. D. Hewitson, Y. Zhang, and D. J. Kelly Relaxin Ameliorates Fibrosis in Experimental Diabetic Cardiomyopathy Endocrinology, July 1, 2008; 149(7): 3286 - 3293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Yan Wen, Y.-Y. Zhao, M. L. Polan, and B. Chen Effect of Relaxin on TGF-{beta}1 Expression in Cultured Vaginal Fibroblasts From Women With Stress Urinary Incontinence Reproductive Sciences, March 1, 2008; 15(3): 312 - 320. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Needle, K. Piparo, D. Cole, C. Worrall, I. Whitehead, G. Mahon, and L. T. Goldsmith Protein Kinase A-Independent cAMP Stimulation of Progesterone in a Luteal Cell Model Is Tyrosine Kinase Dependent but Phosphatidylinositol-3-Kinase and Mitogen-Activated Protein Kinase Independent Biol Reprod, July 1, 2007; 77(1): 147 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jeyabalan, J. Novak, K. D. Doty, J. Matthews, M. C. Fisher, L. J. Kerchner, and K. P. Conrad Vascular Matrix Metalloproteinase-9 Mediates the Inhibition of Myogenic Reactivity in Small Arteries Isolated from Rats after Short-Term Administration of Relaxin Endocrinology, January 1, 2007; 148(1): 189 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Halls, R. A. D. Bathgate, and R. J. Summers Comparison of Signaling Pathways Activated by the Relaxin Family Peptide Receptors, RXFP1 and RXFP2, Using Reporter Genes J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 281 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Scott, S. Layfield, Y. Yan, S. Sudo, A. J. W. Hsueh, G. W. Tregear, and R. A. D. Bathgate Characterization of Novel Splice Variants of LGR7 and LGR8 Reveals That Receptor Signaling Is Mediated by Their Unique Low Density Lipoprotein Class A Modules J. Biol. Chem., November 17, 2006; 281(46): 34942 - 34954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jeyabalan, L. J. Kerchner, M. C. Fisher, J. T. McGuane, K. D. Doty, and K. P. Conrad Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats J Appl Physiol, June 1, 2006; 100(6): 1955 - 1963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Figueiredo, A. L. Mui, C. C. Nelson, and M. E. Cox Relaxin Stimulates Leukocyte Adhesion and Migration through a Relaxin Receptor LGR7-dependent Mechanism J. Biol. Chem., February 10, 2006; 281(6): 3030 - 3039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Samuel Relaxin: Antifibrotic Properties and Effects in Models of Disease Clin. Med. Res., November 1, 2005; 3(4): 241 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R W. Stones and K. Vits Pelvic girdle pain in pregnancy BMJ, July 30, 2005; 331(7511): 249 - 250. [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Nguyen and C. W. Dessauer Relaxin Stimulates Protein Kinase C {zeta} Translocation: Requirement for Cyclic Adenosine 3',5'-Monophosphate Production Mol. Endocrinol., April 1, 2005; 19(4): 1012 - 1023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-Y. Lee, S. Zhao, P. A. Fields, and O. D. Sherwood The Extent to which Relaxin Promotes Proliferation and Inhibits Apoptosis of Cervical Epithelial and Stromal Cells Is Greatest during Late Pregnancy in Rats Endocrinology, January 1, 2005; 146(1): 511 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Conrad Mechanisms of Renal Vasodilation and Hyperfiltration During Pregnancy Reproductive Sciences, October 1, 2004; 11(7): 438 - 448. [Abstract] [PDF]
|
|
|
|
 |
|
 K. P. Conrad and J. Novak Emerging role of relaxin in renal and cardiovascular function Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. D. Sherwood Relaxin's Physiological Roles and Other Diverse Actions Endocr. Rev., April 1, 2004; 25(2): 205 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. T. Goldsmith, G. Weiss, S. Palejwala, T. M. Plant, A. Wojtczuk, W. C. Lambert, N. Ammur, D. Heller, J. H. Skurnick, D. Edwards, et al. Relaxin regulation of endometrial structure and function in the rhesus monkey PNAS, March 30, 2004; 101(13): 4685 - 4689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jeyabalan, J. Novak, L. A. Danielson, L. J. Kerchner, S. L. Opett, and K. P. Conrad Essential Role for Vascular Gelatinase Activity in Relaxin-Induced Renal Vasodilation, Hyperfiltration, and Reduced Myogenic Reactivity of Small Arteries Circ. Res., December 12, 2003; 93(12): 1249 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Silvertown, B. J. Geddes, and A. J. S. Summerlee Adenovirus-Mediated Expression of Human Prorelaxin Promotes the Invasive Potential of Canine Mammary Cancer Cells Endocrinology, August 1, 2003; 144(8): 3683 - 3691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Nguyen, L. Yang, B. M. Sanborn, and C. W. Dessauer Phosphoinositide 3-Kinase Activity Is Required for Biphasic Stimulation of Cyclic Adenosine 3',5'-Monophosphate by Relaxin Mol. Endocrinol., June 1, 2003; 17(6): 1075 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dschietzig, C. Bartsch, C. Richter, M. Laule, G. Baumann, and K. Stangl Relaxin, a Pregnancy Hormone, Is a Functional Endothelin-1 Antagonist: Attenuation of Endothelin-1-Mediated Vasoconstriction by Stimulation of Endothelin Type-B Receptor Expression via ERK-1/2 and Nuclear Factor-{kappa}B Circ. Res., January 10, 2003; 92(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Renegar and C. R. Owens III Measurement of Plasma and Tissue Relaxin Concentrations in the Pregnant Hamster and Fetus Using a Homologous Radioimmunoassay Biol Reprod, August 1, 2002; 67(2): 500 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Palejwala, L. Tseng, A. Wojtczuk, G. Weiss, and L. T. Goldsmith Relaxin Gene and Protein Expression and Its Regulation of Procollagenase and Vascular Endothelial Growth Factor in Human Endometrial Cells Biol Reprod, June 1, 2002; 66(6): 1743 - 1748. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
